Viraferonpeg 100mcg Injection

Product Overview

About Viraferonpeg 100mcg Injection

Viraferonpeg 100mcg Injection is a prescription medicine containing Pegylated Interferon Alpha 2B. It is formulated as a sterile, preservative‑free solution for subcutaneous injection. The product is intended for use under the supervision of a qualified healthcare professional. Each vial contains 100 micrograms of active drug in a volume suitable for a single dose. The medication is supplied in a single‑use vial and should be stored in a refrigerator until use. Viraferonpeg 100mcg Injection is not intended for self‑administration without medical guidance. The product is manufactured in accordance with Good Manufacturing Practice regulations and is subject to regulatory approval in the jurisdictions where it is marketed. The formulation is designed to provide a sustained release of interferon activity, allowing for a reduced dosing frequency compared with non‑pegylated interferon preparations.

Key Benefits & Uses

• Provides antiviral activity against a range of viral infections.
• Helps modulate the immune response to reduce viral replication.
• Offers a longer half‑life, enabling less frequent dosing.

Active Ingredient & Action

The active ingredient, Pegylated Interferon Alpha 2B, is a recombinant protein that mimics the natural interferon alpha. It binds to interferon receptors on target cells, triggering a cascade of antiviral and immunomodulatory effects. The pegylation process extends the drug’s circulation time, enhancing its therapeutic efficacy while reducing the frequency of injections required.

Important Notes

Viraferonpeg 100mcg Injection should be used only as prescribed by a healthcare professional. Patients should be monitored for potential side effects such as flu‑like symptoms, injection site reactions, and changes in blood counts. The medication must be stored refrigerated and protected from light. Do not use if the vial is damaged or if the solution appears cloudy or discolored. Patients should inform their clinician of any other medications they are taking to avoid potential drug interactions. The product is not approved for use in pregnant or lactating women unless the benefits outweigh the risks. For detailed safety information, consult the prescribing information or a qualified healthcare provider.